These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 12569361)
1. Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo. Karnauskas R; Niu Q; Talapatra S; Plas DR; Greene ME; Crispino JD; Rudin CM Oncogene; 2003 Feb; 22(5):688-98. PubMed ID: 12569361 [TBL] [Abstract][Full Text] [Related]
2. IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells. Sade H; Sarin A Eur J Immunol; 2003 Apr; 33(4):913-9. PubMed ID: 12672057 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Portis T; Longnecker R Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852 [TBL] [Abstract][Full Text] [Related]
4. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. Nuñez G; London L; Hockenbery D; Alexander M; McKearn JP; Korsmeyer SJ J Immunol; 1990 May; 144(9):3602-10. PubMed ID: 2184193 [TBL] [Abstract][Full Text] [Related]
5. A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. Verhaegen M; Bauer JA; Martín de la Vega C; Wang G; Wolter KG; Brenner JC; Nikolovska-Coleska Z; Bengtson A; Nair R; Elder JT; Van Brocklin M; Carey TE; Bradford CR; Wang S; Soengas MS Cancer Res; 2006 Dec; 66(23):11348-59. PubMed ID: 17145881 [TBL] [Abstract][Full Text] [Related]
6. Transforming activity of the RL-akt gene, a c-akt gene activated by long terminal repeat insertion in murine leukemia RL(male symbol)1 cells. Tanino M; Matsuo M; Uenaka A; Tsukuda K; Ouchida M; Nakayama E; Shimizu K Mol Carcinog; 1999 Dec; 26(4):286-97. PubMed ID: 10569805 [TBL] [Abstract][Full Text] [Related]
7. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Lilly M; Sandholm J; Cooper JJ; Koskinen PJ; Kraft A Oncogene; 1999 Jul; 18(27):4022-31. PubMed ID: 10435626 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway. Sekharam M; Zhao H; Sun M; Fang Q; Zhang Q; Yuan Z; Dan HC; Boulware D; Cheng JQ; Coppola D Cancer Res; 2003 Nov; 63(22):7708-16. PubMed ID: 14633695 [TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Walton MI; Whysong D; O'Connor PM; Hockenbery D; Korsmeyer SJ; Kohn KW Cancer Res; 1993 Apr; 53(8):1853-61. PubMed ID: 8467505 [TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes. Karlsson R; Engström M; Jönsson M; Karlberg P; Pronk CJ; Richter J; Jönsson JI J Leukoc Biol; 2003 Nov; 74(5):923-31. PubMed ID: 12960281 [TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival. Chandrasekher G; Sailaja D Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065 [TBL] [Abstract][Full Text] [Related]
12. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Shankar S; Srivastava RK Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930 [TBL] [Abstract][Full Text] [Related]
13. Macrophage colony-stimulating factor-, granulocyte-macrophage colony-stimulating factor-, or IL-3-dependent survival of macrophages, but not proliferation, requires the expression of p21(Waf1) through the phosphatidylinositol 3-kinase/Akt pathway. Comalada M; Xaus J; Sánchez E; Valledor AF; Celada A Eur J Immunol; 2004 Aug; 34(8):2257-67. PubMed ID: 15259023 [TBL] [Abstract][Full Text] [Related]
14. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth. Liu X; Powlas J; Shi Y; Oleksijew AX; Shoemaker AR; De Jong R; Oltersdorf T; Giranda VL; Luo Y Anticancer Res; 2004; 24(5A):2697-704. PubMed ID: 15517874 [TBL] [Abstract][Full Text] [Related]
15. Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt. Asnaghi L; Calastretti A; Bevilacqua A; D'Agnano I; Gatti G; Canti G; Delia D; Capaccioli S; Nicolin A Oncogene; 2004 Jul; 23(34):5781-91. PubMed ID: 15208671 [TBL] [Abstract][Full Text] [Related]
17. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression. Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324 [TBL] [Abstract][Full Text] [Related]
18. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells. Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450 [TBL] [Abstract][Full Text] [Related]
19. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347 [TBL] [Abstract][Full Text] [Related]